Submit your Celebrex claim details for a free, no obligation case review
Get Started:
Recent Celebrex information indicates that the potential side effects are more prevalent and more serious than originally thought. Celebrex information presented by various sources shows that many risks associated with Vioxx apply to Celebrex. Celebrex information continues to be released, as studies are ongoing and since the drug is fairly new, Celebrex information is by no means at a definitive point yet.
The Wall Street Journal published Celebrex information in a story run just after the drug’s public debut. According to the story, there was Celebrex information linking a number of deaths to use of Celebrex. In addition to providing new Celebrex information regarding the drug’s potential to cause gastrointestinal hemorrhaging, the story claimed that Celebrex information existed that potentially linked Celebrex to heart and kidney problems.
Although not as widely available, Celebrex information mirrors many of the findings of Vioxx studies. All potential users should review Celebrex information carefully, and should discuss their medical histories with their physicians. For patients already taking Celebrex, Celebrex information may confirm their suspicions about side effects, or may help prevent potentially dangerous drug interactions. Celebrex information is available in many locations, including through the FDA web site. In addition, many doctors provide Celebrex information to patients who request it.
After COX-2 painkillers – Vioxx, Celebrex and Bextra- came under scrutiny when cardiovascular risks were associated to the drugs some drugmakers saw this as an opportunity to try to capitalize on the events.
Vioxx went off the market in Se...
Merck & Co. and Pfizer Inc. have been criticized for their aggressive marketing campaigns for its COX-2 drugs, putting scrutiny on pharmaceutical advertising as a whole. Between December 2003 and November 2004, pharmaceutical ad spending increased 30...
A three-day FDA Advisory Committee meeting has wrapped, but the COX-2 drugs controversy is still not resolved. Although the panel of government medical experts advised keeping the drugs, including Pfizer Inc.’s Celebrex and Bextra, on the market, new...
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice